扬子江药业集团江苏紫龙药业

Jiangsu Zilong Pharmaceutical is a core subsidiary of the Yangzijiang Pharmaceutical Group, established as a high-end manufacturing and R&D hub in Changzhou, China. The company specializes in the production of complex injectables, solid oral dosages, and biological products across multiple therapeutic areas including oncology, anti-infectives, and anesthesia. Zilong Pharmaceutical is recognized for its Smart Factory initiative, utilizing advanced automation and digital management systems to ensure compliance with international GMP standards. As a key component of Yangzijiang's industrial chain, it supports the group's transition from generic manufacturing to innovative drug development. The facility serves both domestic and international markets, emphasizing high-quality standards and technological innovation. It represents one of the most advanced pharmaceutical production bases in the Jiangsu province, integrating green manufacturing practices with high-efficiency output.